IDEAYA Biosciences (IDYA) Current Assets (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Current Assets data on file, last reported at $696.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 1.66% year-over-year to $696.1 million; the trailing twelve-month figure through Mar 2026 stood at $696.1 million (down 1.66% YoY), and the FY2025 full-year result was $666.7 million, down 3.33% from the prior year.
• Current Assets rose to $696.1 million in Q1 2026, from $666.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $932.2 million in Q3 2024 to a low of $256.0 million in Q1 2022.
• A 5-year average of $573.9 million and a median of $666.7 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slipped 16.91% in 2022 and surged 106.23% in 2024, its largest moves.
• Tracing IDYA's Current Assets over 5 years: stood at $370.5 million in 2022, then jumped by 43.78% to $532.6 million in 2023, then gained by 29.49% to $689.7 million in 2024, then fell by 3.33% to $666.7 million in 2025, then gained by 4.41% to $696.1 million in 2026.
• Business Quant data shows IDYA's Current Assets at $696.1 million in Q1 2026, $666.7 million in Q4 2025, and $802.7 million in Q3 2025.